Related Experiment Video

Updated: Jul 13, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.4K

Canadine inhibits epithelial mesenchymal transformation of HPV-negative cervical cancer

Yan Ma, Qian-Qian Yang1, Dong-Mei Gu1

  • 1Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.

Tissue Barriers
|October 11, 2023
PubMed

Insights

Canadine effectively inhibits cervical cancer progression by blocking epithelial-mesenchymal transition (EMT). This natural compound targets MAGEA3, offering a potential new therapeutic strategy for HPV-negative cervical cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cervical cancer treatment remains critical, even with HPV vaccination, necessitating research into HPV-negative cases.
  • Epithelial-mesenchymal transition (EMT) is a key process in cancer progression and metastasis.

Purpose of the Study:

  • To investigate the effect of Canadine on inhibiting EMT in cervical cancer.
  • To explore the molecular mechanism underlying Canadine's action, focusing on MAGEA3.

Main Methods:

  • Utilized immunoblotting, wound healing, and tumor invasion assays with HT-3 cells (HPV-negative).
  • Analyzed gene expression data from the GEO database.
  • Employed small interfering RNA (siRNA) and overexpression plasmids for MAGEA3 manipulation.

Main Results:

  • Canadine inhibited EMT, proliferation, and migration of HT-3 cells.
  • Canadine reduced the expression of MAGEA3 and other cervical tumor-associated genes.
  • Decreasing MAGEA3 levels phenocopied Canadine's effects, while MAGEA3 overexpression counteracted Canadine's inhibition of EMT.

Conclusions:

  • Canadine inhibits EMT in cervical cancer by targeting and reducing MAGEA3 expression.
  • Canadine presents a potential therapeutic agent for cervical cancer, particularly HPV-negative types.
Keywords:
CanadineE-cadherinMAGEA3N-cadherinepithelial-mesenchymal transition

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.4K
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.0K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K